New Antibiotic Resistance Test Developed By AGPlus DiagnosticsGemma Cann2024-11-28T15:23:59+00:00August 25th, 2021|Colworth Park, News|
Concepta Inks Global License Agreement With Abingdon HealthGemma Cann2024-11-28T15:24:29+00:00August 25th, 2021|Colworth Park, News|
Stream Bio Works With MIP Diagnostics On Rapid Diagnostic And Mass Screening Test For COVID-19Gemma Cann2024-11-28T15:24:51+00:00August 25th, 2021|Colworth Park, News|
Veravas And MIP Diagnostics Announce International Agreement For Improved DiagnosticsGemma Cann2024-11-28T15:25:07+00:00August 25th, 2021|Colworth Park, News|
AgPlus Developing Two Assays To Support The COVID-19 Diagnostic EffortGemma Cann2024-11-28T15:27:12+00:00August 25th, 2021|Colworth Park, News|
MIP Diagnostics Signs Significant Commercial AgreementGemma Cann2022-06-30T12:00:27+01:00August 25th, 2021|Colworth Park, News|
Harrison Street And Trinity Acquire Portfolio Of Five UK Life Sciences PropertiesGemma Cann2024-11-28T16:54:36+00:00August 25th, 2021|News|
Almac Discovery Expands Disease Focus Into Respiratory DiseaseGemma Cann2024-11-26T12:21:23+00:00July 20th, 2021|Article, Edinburgh Technopole|
NanoSyrinx Announces Oversubscribed £6.2m Seed Funding RoundGemma Cann2022-06-30T12:01:24+01:00July 19th, 2021|Investment, News|
Maxwellia’s Lovima Contraceptive Pill Granted MHRA LicenceGemma Cann2022-06-30T12:01:39+01:00July 14th, 2021|News|
